Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in this Registration Statement on Form S-3 and related prospectuses of MapLight Therapeutics, Inc. of our report dated March 26, 2026, relating to the consolidated financial statements of MapLight Therapeutics, Inc. and its subsidiary, appearing in the Annual Report on Form 10-K of MapLight Therapeutics, Inc. for the year ended December 31, 2025.

We also consent to the references to our firm under the headings “Experts” in such prospectuses.

 

/s/ RSM US LLP
Boston, Massachusetts
November 16, 2026

 

1